Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA pauses several trials of Merck’s investigational HIV drug

December 16, 2021
Business Services

The FDA has placed holds on several clinical trials for the oral and implant formulations of investigation drug islatravir (MK-8591), …

News

European Commission backs Johnson & Johnson COVID-19 booster for adults

December 16, 2021
Business Services

The EC has recommended a booster dose of Johnson & Johnson’s COVID-19 vaccine at least two months after a first …

News

Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation

December 15, 2021
Research and Development

Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …

News

Bionaut Labs and Candel Therapeutics collaborate to deliver immunotherapies

December 15, 2021
Research and Development

Bionaut Labs, and Candel Therapeutics, have announced a strategic collaboration to investigate the use of Bionaut’s remote-controlled microscale robots for …

News

Positive results in Phase III trial of candidemia and invasive candidiasis

December 15, 2021
Research and Development

Cidara Therapeutics and Mundipharma have announced positive topline data from the ReSTORE Phase III clinical trial, evaluating the efficacy and …

News

Sanofi and GSK announce positive booster data for COVID-19 vaccine candidate

December 15, 2021
Research and Development

Sanofi and GSK have announced positive preliminary booster data for their COVID-19 vaccine candidate, and continuation of their Phase III …

News

European Commission approves Pfizer drug for adults with moderate-to-severe atopic dermatitis

December 14, 2021
Manufacturing and Production

The EC has approved the investigational once-daily Janus kinase 1 (JAK1) inhibitor, abrocitinib, for the treatment of moderate-to-severe atopic dermatitis …

News

India’s Serum Novavax jab to be launched for children in six months

December 14, 2021
Medical Communications

The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six …

News

Phase III trial results gives hope to B-Cell lymphoma patients

December 14, 2021
Manufacturing and Production

Bristol Myers Squibb (BMS) reported that interim assessment data from the Phase III TRANSFORM clinical trial of Breyanzi (lisocabtagene maraleucel; …

News
astrazeneca_plaque

Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy

December 14, 2021
Medical Communications

Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …

News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …

Appointment
credit_-_crevis_shutterstock_340710245_720

CAR-T therapy trials show promise for earlier use in lymphoma

December 13, 2021
Sales and Marketing

Earlier use of chimeric antigen receptor (CAR) T-cell therapy for relapse B-cell lymphoma has demonstrated efficacy at substantially improving outcomes …

News

New clinical trial testing diabetes drug for reducing risk of Alzheimer’s

December 13, 2021
Sales and Marketing

A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …

News

UK government sets new booster target

December 13, 2021
Sales and Marketing

The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …

News

Feedback receives funding for cloud-based tuberculosis programme

December 13, 2021
Sales and Marketing

Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …

News

CDC authorise Pfizer boosters for 16- and 17-year-olds

December 10, 2021
Medical Communications

The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …

News

FDA approves expansion for ZYNRELEF

December 10, 2021
Medical Communications

The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …

News

Novartis announces positive results from Phase III trial of Beovu

December 9, 2021
Business Services

Novartis have announced the first interpretable results from year two (week 100) of the Phase III KESTREL study. KESTREL assessed …

News

Pfizer says COVID-19 booster shot is promising against Omicron variant

December 9, 2021

The companies said that the three doses provide a similar level of antibodies against Omicron, compared to that of two …

News

FDA approval for first CGP test for melanoma therapeutics

December 9, 2021
Business Services

The FDA has granted Foundation Medicine approval for its companion diagnostic, FoundationOne®CDx, for two groups of current and future FDA-approved …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026